[Retracted] Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis

<div>Survival analysis. High expression of (a) VCAN, (b) PLAU, (c) MSLN, and (d) FN1 in pancreatic cancer correlated with poor prognosis.</div>

Disease Markers

fig6

Figure 6

Figure 6: [Retracted] Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis 

Figure 6 | [Retracted] Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis 